** Shares of Austco Healthcare AHC.AX rise as much as 17.9% to A$0.395, their highest level since November 10, 2024
** The healthcare communication firm sees FY25 EBITDA between A$12.5 million ($8.19 million) and A$13.5 million, compared with A$8.1 million reported a year ago
** Also sees higher FY25 revenue of A$80 million - A$82 million
** Co says performance driven by strategic acquisitions
** YTD, shares up 41.8%
($1 = 1.5263 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.